Heart (Cardiomyopathy hypertrophic)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Cardiomyopathy hypertrophic).php on line 2
Heart (Cardiomyopathy hypertrophic)

LE WE PMID CA

Heart (Cardiomyopathy hypertrophic)

1259

Herz (Kardiomyopathie Hypertrophe)

Aortic valve (Stenosis and artificial valve)

Heart (Arrhythmogenic right ventricular dysplasia)

Heart (Cardiomyopathy BASKET)

Heart (Cardiomyopathy dilated)

Heart (Cardiomyopathy hypertrophic)

Heart (Coronary heart disease NoReflow)

Heart (Echocardiography)

Heart (MRT)

Interventional cardiology

MLP CSRP3 CRP3

MyBP C

MYH7

TNNI3

2006 1	Management of hypertrophic cardiomyopathy. [16735335] BMJ 332(7552): 1251-5 (2006)
2006 2	Hypertrophic cardiomyopathy. [16394705] Anesthesiology 104(1): 183-92 (2006)
2006 3	Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. [16908721] Heart 92(9): 1339-44 (2006)
2002 4	Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. [11796562] Heart 87(2): 169-76 (2002)
2001 5	Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy. [11711479] Heart 86(6): 709-14 (2001)
1995 6	How should we manage symptomatic aortic stenosis in the patient who is 80 or older? [8562230] Br Heart J 74(5): 481-4 (1995)
1994 7	Natural history of hypertrophic cardiomyopathy. [7873316] Br Heart J 72(6 Suppl): S10-2 (1994)
1990 8	Hypertrophic cardiomyopathy: one disease or several? [2149030] Br Heart J 63(5): 263-4 (1990)
2008 9	Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. [19936195] Curr Cardiol Rev 4(3): 193-7 (2008)
2007 10	Intracardiac echocardiography guidance for alcohol septal ablation in hypertrophic obstructive cardiomyopathy. [17470972] J Invasive Cardiol 19(5): E134-6 (2007)
2009 11	Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. [19889657] Eur J Echocardiogr 10(8): iii9-14 (2009)
1999 12	Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. [10615387] Cardiovasc Res 44(1): 20-36 (1999)
2003 13	Hypertrophic cardiomyopathy: from gene defect to clinical disease. [12643345] Cell Res 13(1): 9-20 (2003)
1978 14	[Classification of jaundice caused by intrahepatic cholestasis and etiopathogenetic considerations]. [33017] Minerva Chir 33(22): 1647-52 (1978)
1998 15	Familial hypertrophic cardiomyopathy: from mutations to functional defects. [9742053] Circ Res 83(6): 580-93 (1998)
2008 16	Management of symptoms in hypertrophic cardiomyopathy. [18212300] Circulation 117(3): 429-39 (2008)
2006 17	A contemporary approach to hypertrophic cardiomyopathy. [16785342] Circulation 113(24): e858-62 (2006)
2005 18	Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. [16009810] Circulation 112(2): 293-6 (2005)
1995 19	Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. [7586349] Circulation 92(9): 2488-95 (1995)
1995 20	Hypertrophic cardiomyopathy. Clinical spectrum and treatment. [7671349] Circulation 92(7): 1680-92 (1995)
2009 21	Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. [19136482] Eur Heart J 30(2): 139-51 (2009)
2006 22	The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? [16818455] Eur Heart J 27(16): 1895-7 (2006)
2003 23	American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. [14585256] Eur Heart J 24(21): 1965-91 (2003)
2003 24	Hypertrophic cardiomyopathy-the clinical challenge of managing a hereditary heart condition. [12643880] Eur Heart J 24(6): 496-8 (2003)
2000 25	Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy. [10739723] Eur Heart J 21(9): 704-7 (2000)
1999 26	New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence. [10462461] Eur Heart J 20(18): 1292-4 (1999)
2006 27	The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention. [16606861] Heart 92(9): 1191-3 (2006)
2008 28	Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm. [18687252] J Am Coll Cardiol 52(7): 567-8 (2008)
2002 29	Hypertrophic cardiomyopathy: a systematic review. [11886323] JAMA 287(10): 1308-20 (2002)
1991 30	Problems in diagnosis and management of hypertrophic cardiomyopathy. [1754522] Postgrad Med J 67(790): 713-8 (1991)
2009 31	Contemporary treatment of hypertrophic cardiomyopathy. [19568388] Tex Heart Inst J 36(3): 194-204 (2009)
1995 32	Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy. [7647595] Tex Heart Inst J 22(2): 126-33 (1995)
1994 33	Molecular basis of hypertrophic and dilated cardiomyopathy. [8180512] Tex Heart Inst J 21(1): 6-15 (1994)
1979 34	Nonobstructive and obstructive hypertrophic cardiomyopathies. [375589] West J Med 130(4): 325-49 (1979)
2007 35	Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? [17719467] J Am Coll Cardiol 50(9): 831-4 (2007)
2005 36	The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy. [16053961] J Am Coll Cardiol 46(3): 477-9 (2005)
2003 37	American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. [14607462] J Am Coll Cardiol 42(9): 1687-713 (2003)
2007 38	MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. [18029870] AJR Am J Roentgenol 189(6): 1344-52 (2007)
2007 39	MRI of hypertrophic cardiomyopathy: part I, MRI appearances. [18029869] AJR Am J Roentgenol 189(6): 1335-43 (2007)
2007 40	Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy. [18053460] Mayo Clin Proc 82(12): 1516-22 (2007)
2008 41	Identification of myofilament mutations: its role in the diagnosis and management of hypertrophic cardiomyopathy. [18533077] Mayo Clin Proc 83(6): 626-7 (2008)
2005 42	Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well. [15851609] Circulation 111(16): 2016-8 (2005)
2009 43	The science of uncertainty and the art of probability: syncope and its consequences in hypertrophic cardiomyopathy. [19349332] Circulation 119(13): 1697-9 (2009)
2008 44	Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity. [18391120] Circulation 117(14): 1775-7 (2008)
2010 45	A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. [21116069] Circ J 75(1): 28-37 (2010)
2010 46	Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy. [20439260] Eur Heart J 31(13): 1551-3 (2010)
2010 47	DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. [20299350] Eur Heart J 31(8): 926-35 (2010)
2008 48	Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. [18385119] Eur Heart J 29(9): 1160-7 (2008)
2011 49	Genetic testing strategies for the diagnosis of hypertrophic cardiomyopathy. [21425740] Rev Port Cardiol 30(1): 19-23 (2011)
2005 50	Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. [16566405] Rev Port Cardiol 24(12): 1463-76 (2005)
2005 51	The enigmatic diversity of hypertrophic cardiomyopathy. [16566406] Rev Port Cardiol 24(12): 1479-84 (2005)
2005 52	Malignant mutations in hypertrophic cardiomyopathy: fact or fancy? [16335287] Rev Port Cardiol 24(9): 1137-46 (2005)
2010 53	The role of cardiac magnetic resonance in hypertrophic cardiomyopathy. [20391901] Rev Port Cardiol 29(1): 79-93 (2010)
2008 54	Hypertrophic cardiomyopathy--state of the art in 2007. [18717215] Rev Port Cardiol 27(5): 625-37 (2008)
2010 55	Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. [20118111] Europace 12(3): 313-21 (2010)
2011 56	The diagnosis and treatment of hypertrophic cardiomyopathy. [21505608] Dtsch Arztebl Int 108(13): 209-15 (2011)
2005 57	Sudden death and hypertrophic cardiomyopathy: a review. [15861263] Can J Cardiol 21(5): 441-8 (2005)
2007 58	Hypertrophic cardiomyopathy in children, teenagers and young adults. [17715614] Hellenic J Cardiol 48(4): 228-33 (2007)
2009 59	Alcohol septal ablation in hypertrophic obstructive cardiomyopathy. [19942565] Hellenic J Cardiol 50(6): 511-22 (2009)
2007 60	Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety. [18058273] Swiss Med Wkly 137(47-48): 657-9 (2007)
2008 61	Diagnostic evaluation of hypertrophic cardiomyopathy in its clinical and preclinical phases. [18660946] Arq Bras Cardiol 91(1): 51-62 (2008)
2009 62	Pacemaker therapy in hypertrophic obstructive cardiomyopathy: still awaiting the evidence. [19889331] Rev Esp Cardiol 62(11): 1217-20 (2009)
2002 63	Phenotypic diversity in hypertrophic cardiomyopathy. [12351586] Hum Mol Genet 11(20): 2499-506 (2002)
2004 64	Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up. [15212123] Tex Heart Inst J 31(2): 137-42 (2004)
2004 65	Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis. [15590362] Anadolu Kardiyol Derg 4(4): 327-30 (2004)
2005 66	Hypertrophic cardiomyopathy: the pathological features and the molecular pathogenesis. [15755711] Anadolu Kardiyol Derg 5(1): 70; author reply 70-2 (2005)
2011 67	MLP (muscle LIM protein) as a stress sensor in the heart. [21484537] Pflugers Arch 462(1): 135-42 (2011)
2010 68	Percutaneous alcohol septal ablation following surgical myectomy. [20679680] J Invasive Cardiol 22(8): E147-9 (2010)
2010 69	Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. [20404382] Ann Intern Med 152(8): 513-20, W181 (2010)
2010 70	Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. [20197511] Circ Cardiovasc Interv 3(2): 97-104 (2010)
2010 71	Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM). [20390065] Neth Heart J 18(3): 144-59 (2010)
2009 72	Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. [20087449] Neth Heart J 17(12): 464-9 (2009)
2009 73	Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. [19808347] Circ Heart Fail 2(3): 253-61 (2009)
2010 74	Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment. [20236538] Cardiovasc Ultrasound 8(-): 7 (2010)
2010 75	Sarcomere gene mutations in hypertrophy and heart failure. [20559778] J Cardiovasc Transl Res 3(4): 297-303 (2010)
2009 76	Experimental therapies in hypertrophic cardiomyopathy. [20560006] J Cardiovasc Transl Res 2(4): 483-92 (2009)
2010 77	Hypertrophic cardiomyopathy: from genetics to treatment. [20503496] Eur J Clin Invest 40(4): 360-9 (2010)
2010 78	Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. [21135371] Circulation 122(23): 2430-40; discussion 2440 (2010)
PMC 79	Alcohol septal ablation - an evolving procedure. [23253413] Indian Heart J 64(6):591-3 (2012)
PMC 80	Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy? [23027595] Interact Cardiovasc Thorac Surg 16(1):5-9 (2013)
PMC 81	Mutation that causes hypertrophic cardiomyopathy increases force production in human beta-cardiac myosin. [23852727] Proc Natl Acad Sci U S A 110(31):12507-8 (2013)
PMC 82	Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. [23255317] Circ Cardiovasc Genet 6(1):10-8 (2013)
PMC 83	Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment. [23109605] CMAJ 185(2):127-34 (2013)
PMC 84	MT-CYB mutations in hypertrophic cardiomyopathy. [24498601] Mol Genet Genomic Med 1(1):54-65 (2013)
PMC 85	Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives. [24575171] World J Cardiol 6(2):26-37 (2014)
PMC 86	Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy acute results and 6 months' followup in 19 patients. [C3861207] Indian Heart J 64(1):112-3 (2012)
PMC 87	Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy. [24719675] Curr Cardiovasc Imaging Rep 7(): (2014)
PMC 88	Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. [23271053] FASEB J 27(4):1460-7 (2013)
PMC 89	Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison. [24749114] Glob Cardiol Sci Pract 2013(4):405-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Cardiomyopathy hypertrophic).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Cardiomyopathy hypertrophic).php on line 92